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Background: Pulmonary Arterial Hypertension (PAH) is characterized by endothelial dysfunction and vascular remodeling. The role of oxidative 
stress and its relation with peripheral endothelial function and pulmonary vascular response to vasodilators remains unknown.
Methods: PAH patients diagnosed by right cardiac catheterization with a pulmonary CT-scan negative for pulmonary embolism and a control group 
matched by age and gender were included. Malondialdehyde (MDA), xanthine oxidase (XO) and endothelial linked superoxide dismutase (ecSOD) 
activities, were determined in all subjects. Peripheral endothelium-dependent vasoreactivity was assessed using brachial artery blood flow-mediated 
dilation (FMD). Transthoracic echocardiography pre and post Iloprost inhalation were performed.
Results: Fifteen patients (mean age 37 ± 7 years, 60% female) and 15 controls were included. Baseline measurements are showed in the table 
(mean ± SD): Iloprost in PAH patients improved cardiac output (3.68 ±0.6 L/min to 4.12 ± 1.2; p=0.02) and pulmonary vascular resistance (3.4 ± 
0.9 Wood U to 2.94 ± 1.1; p=0.01). A significant correlation between cardiac output improvement and FMD (R= 0.7, p<0.01) was seen and, ecSOD 
showed a positive correlation with FMD (R= 0.51, p<0.01), and cardiac output improvement (R=0.58, p=0.04).
Conclusions: PAH patients have elevated oxidative stress markers and impaired FMD at baseline. These parameters correlate with pulmonary 
vascular response to vasodilators.
UCA: under curve area; * t-student
PAH Control p*
FMD (%) 2.8 ± 0.6 10.7 ± 0,6 < 0.001
XO (U/mL) 0.039 ± 0.005 0.034 ± 0.004 0.02
MDA (μM) 0.61 ± 0.17 0.34 ± 0.15 < 0.001
ecSOD (UCA) 235.55 ± 133 461.41 ± 33 0.03
